EMA Inspection Findings: CAPA Weaknesses and Preventive Actions
EMA Inspection Findings: CAPA Weaknesses and Preventive Actions What EMA Inspection Findings Teach About CAPA Weaknesses and Preventive Actions Introduction: EMA Oversight and CAPA in Clinical Trials The European Medicines Agency (EMA) plays a central role in ensuring the integrity, safety, and compliance of clinical trials conducted across the European Union. One of the most…
Read More “EMA Inspection Findings: CAPA Weaknesses and Preventive Actions” »